2c2z
From Proteopedia
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
- | Aza-peptide Michael acceptors are a novel class of inhibitors that are | + | Aza-peptide Michael acceptors are a novel class of inhibitors that are potent and specific for caspases-2, -3, -6, -7, -8, -9, and -10. The second-order rate constants are in the order of 10(6) M(-1) s(-1). The aza-peptide Michael acceptor inhibitor 18t (Cbz-Asp-Glu-Val-AAsp-trans-CH=CH-CON(CH(2)-1-Naphth)(2) is the most potent compound and it inhibits caspase-3 with a k(2) value of 5620000 M(-1) s(-1). The inhibitor 18t is 13700, 190, 6.4, 594, 37500, and 173-fold more selective for caspase-3 over caspases-2, -6, -7, -8, -9, and -10, respectively. Aza-peptide Michael acceptors designed with caspase specific sequences are selective and do not show any cross reactivity with clan CA cysteine proteases such as papain, cathepsin B, and calpains. High-resolution crystal structures of caspase-3 and caspase-8 in complex with aza-peptide Michael acceptor inhibitors demonstrate the nucleophilic attack on C2 and provide insight into the selectivity and potency of the inhibitors with respect to the P1' moiety. |
==Disease== | ==Disease== | ||
Line 16: | Line 16: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
- | [[Category: Asgian, J | + | [[Category: Asgian, J L.]] |
- | [[Category: Campbell, A | + | [[Category: Campbell, A J.]] |
- | [[Category: Ekici, O | + | [[Category: Ekici, O D.]] |
[[Category: Ganesan, R.]] | [[Category: Ganesan, R.]] | ||
- | [[Category: Gruetter, M | + | [[Category: Gruetter, M G.]] |
- | [[Category: James, K | + | [[Category: James, K E.]] |
[[Category: Jelakovic, S.]] | [[Category: Jelakovic, S.]] | ||
- | [[Category: Li, Z | + | [[Category: Li, Z Z.]] |
[[Category: Mikolajczyk, J.]] | [[Category: Mikolajczyk, J.]] | ||
- | [[Category: Powers, J | + | [[Category: Powers, J C.]] |
- | [[Category: Salvesen, G | + | [[Category: Salvesen, G S.]] |
[[Category: DTD]] | [[Category: DTD]] | ||
[[Category: apoptosis]] | [[Category: apoptosis]] | ||
Line 43: | Line 43: | ||
[[Category: zymogen]] | [[Category: zymogen]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:44:18 2008'' |
Revision as of 14:44, 21 February 2008
|
CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR
Contents |
Overview
Aza-peptide Michael acceptors are a novel class of inhibitors that are potent and specific for caspases-2, -3, -6, -7, -8, -9, and -10. The second-order rate constants are in the order of 10(6) M(-1) s(-1). The aza-peptide Michael acceptor inhibitor 18t (Cbz-Asp-Glu-Val-AAsp-trans-CH=CH-CON(CH(2)-1-Naphth)(2) is the most potent compound and it inhibits caspase-3 with a k(2) value of 5620000 M(-1) s(-1). The inhibitor 18t is 13700, 190, 6.4, 594, 37500, and 173-fold more selective for caspase-3 over caspases-2, -6, -7, -8, -9, and -10, respectively. Aza-peptide Michael acceptors designed with caspase specific sequences are selective and do not show any cross reactivity with clan CA cysteine proteases such as papain, cathepsin B, and calpains. High-resolution crystal structures of caspase-3 and caspase-8 in complex with aza-peptide Michael acceptor inhibitors demonstrate the nucleophilic attack on C2 and provide insight into the selectivity and potency of the inhibitors with respect to the P1' moiety.
Disease
Known diseases associated with this structure: Autoimmune lymphoproliferative syndrome, type IIB OMIM:[601763], Breast cancer, protection against OMIM:[601763], Hepatocellular carcinoma, somatic OMIM:[601763], Lung cancer, protection against OMIM:[601763]
About this Structure
2C2Z is a Single protein structure of sequence from Homo sapiens with as ligand. Known structural/functional Site: . Full crystallographic information is available from OCA.
Reference
Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10., Ekici OD, Li ZZ, Campbell AJ, James KE, Asgian JL, Mikolajczyk J, Salvesen GS, Ganesan R, Jelakovic S, Grutter MG, Powers JC, J Med Chem. 2006 Sep 21;49(19):5728-49. PMID:16970398
Page seeded by OCA on Thu Feb 21 16:44:18 2008
Categories: Homo sapiens | Single protein | Asgian, J L. | Campbell, A J. | Ekici, O D. | Ganesan, R. | Gruetter, M G. | James, K E. | Jelakovic, S. | Li, Z Z. | Mikolajczyk, J. | Powers, J C. | Salvesen, G S. | DTD | Apoptosis | Aza-asp | Aza-peptide | Clan cd | Complex (protease-inhibitor) | Cpp32 | Cysteine-protease | Hydrolase | Ice | Michael acceptor | Tetramer | Thiol protease | Yama | Zymogen